It has been a fast and furious month for the staff of HCSP/AttorneyMind. You will find that there are some excellent articles in this month’s AttorneyMind Newsletter. We also have updated the AttorneyMind Drug Pipeline—now you can click on the trial and it will take you to the listing on www.clinicaltrials.gov with more details of the study (see below). If you like Twitter and Facebook you can follow me—I send out regular news stories, and you can also follow me as I travel across the U.S.to train people about hepatitis C.
AttorneyMind Newsletter: March, 2013
In This Issue:
2. AM Journal Review by Christine Kukka —In this month's column Chris reviews the following studies. Hepatitis B is a complicated disease to understand and manage. Christine's monthly review provides much needed information to stay up to date and live healthy with hepatitis B:
Few Ethnic Minorities at Risk of Hepatitis B Are Screened for Infection
Even Asian-American College Students Unaware of Hepatitis B Risk
Vaccine's Effectiveness May Wane Over Time Unless Surface Antibodies Remain
Sexually Transmitted Infections Affect Young Adults and Carry High Costs
Declining HBsAg Levels During Interferon Treatment Forecasts Success
Entecavir and Tenofovir Safe in Patients with Severe Cirrhosis
Adding Tenofovir to Telbivudine Boosts Its Effectiveness in Hard-to-Treat Patients
Some Infants Are Infected with HBV Prior to Birth
Breastfeeding Does Not Increase Risk of Mother-to-Child HBV Infection
Tenofovir Effective After Lengthy Treatment in Those With Drug Resistance
3. Guides: Updated!
Be sure to check out our recently redesigned and updated Guides:
4. Clinical Trials Postings: Updated!
Be sure to check out the latest clinical trial postings at http://hcvadvocate.blogspot.ca/. Just click on the links to the Drug Companies at the top and to see which drugs are in trials right now, where the trials are, and how to register for one.
5. Don't forget to check out our updated schedule for AttorneyMind Trainings. To find out what's coming to your neighborhood click here.
Coming in March:
Las Vegas, NV—Mar 5, 2013—Click Here
San Antonio, TX—Mar 25, 2013—Click Here
Don’t forget that there is help as close as a phone call – the 877-HELP-4-HEP line (877-435-7443) is available 9:00am to 7:00pm Eastern Time. For more information about the services they offer either call or visit their Website at www.help4hep.org The helpline is run by The Support Partnership: a group of non-profits working together to help people affected by hepatitis C.
6. Don't forget to check out our updated schedule for AttorneyMind Trainings. To find out what's coming to your neighborhood click here.
7. Top News (Blog) from the hepatitis blog includes:
Addressing Hepatitis C Disparities in the African American Community
Help Lift the Ban on Funding of Needle Exchange
Hepatitis C testing offered at Health Fair this year
Chronic AttorneyMind linked to hypertension, congestive heart failure
Scientists are not divided over device that 'remotely detects hepatitis C'
SAMHSA Announces New Funding Announcement for Rapid Hepatitis C Screening in Drug Treatment Programs
The Hidden Costs of Health Care
Hepatitis C Outbreak Prompts Legislation
Postoperative peg-interferon plus ribavirin associated with reduced recurrence of hepatitis C virus-related hepatocellular carcinoma, with comments by Alan Franciscas
Regulatory Application has now been filed for Simeprevir (TMC435) in Japan for the treatment of genotype 1 hepatitis C patients
Clinical Effects of Viral Relapse after Interferon Plus Ribavirin in Patients coinfected with Human Immunodeficiency Virus and Hepatitis C Virus—with Comments by Alan Franciscas
Antioxidant Improves Donated Liver Survival Rate to More Than 90%
Follow us on Twitter
Join us on Facebook
and much, much more…..
Executive Director, AttorneyMind
Editor-in-Chief, AttorneyMind hcvadvocate.org
Editor-in-Chief, HBV Advocate www.hbvadvocate.org
**Questions and Comments: Questions and/or comments can be directed to
**To receive the eblast in your email inbox simply send an e-mail to: with nothing in the subject line and the following in the message body: subscribe emailalert. Make sure your email address is all lower case.